MAM
SCPH

Meeder Asset Management’s scPharmaceuticals SCPH Stock Holding History

Meeder Asset Management’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-729
Closed -$6K – 2410
2020
Q1 		$6K Sell
729
-361
-33% -$2.62K ﹤0.01% 1726
2019
Q4 		$6K Hold
1,090
– – ﹤0.01% 1735
2019
Q3 		$6K Buy
1,090
+123
+13% +$694 ﹤0.01% 1711
2019
Q2 		$3K Buy
967
+563
+139% +$1.84K ﹤0.01% 1807
2019
Q1 		$1K Buy
404
+129
+47% +$443 ﹤0.01% 1638
2018
Q4 		$1K Buy
+275
New +$1.29K ﹤0.01% 1648

Other funds holding SCPH

O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $699M AUM 600.17% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
EP
Eversept Partners New York $1.52B AUM 121.13% 1-Year Est. Return